Berends F J, Schep N, Cuesta M A, Bonjer H J, Kappers-Klunne M C, Huijgens P, Kazemier G
Department of General Surgery, Ziekenhuis Rijnstate, Arnhem, The Netherlands.
Surg Endosc. 2004 May;18(5):766-70. doi: 10.1007/s00464-003-9140-7. Epub 2004 Feb 2.
Laparoscopic splenectomy (LS) for idiopathic thrombocytopenic purpura (ITP) appears, when compared to open splenectomy (OS), associated with immediate important advantages. However, in a number of patients splenectomy does not lead to an adequate response, or after initial adequate response a relapse occurs after some time. A relapse may be associated to the presence of accessory spleens and splenosis. The purpose of this study was to compare the operative outcome and the hematological results on the long term of a series of LS with a historic series of OS for the treatment of ITP.
A retrospective review was done of 50 consecutive patients who underwent LS for ITP. Patient characteristics, outcome of surgery, and hematological results were compared to a historical group of patients who underwent conventional splenectomy for ITP (n = 31). Response to splenectomy was defined in three groups: complete remission, partial remission, and no response. Grouping was based on hematological data.
Concerning operative outcome and postoperative complications, there was a significant difference in favor of LS. Moreover, the hematological outcome of both groups showed no differences after a median period of 66 months (OS) and 35 months (LS), respectively.
Hematological results after laparoscopic splenectomy for ITP are comparable to those after open splenectomy in both the short and the long term.
与开放性脾切除术(OS)相比,腹腔镜脾切除术(LS)治疗特发性血小板减少性紫癜(ITP)似乎具有直接的重要优势。然而,在一些患者中,脾切除术并未导致充分的反应,或者在最初的充分反应后,一段时间后会复发。复发可能与副脾和脾组织异位的存在有关。本研究的目的是比较一系列腹腔镜脾切除术(LS)与一组历史开放性脾切除术(OS)治疗ITP的手术结果和长期血液学结果。
对50例连续接受腹腔镜脾切除术治疗ITP的患者进行回顾性研究。将患者的特征、手术结果和血液学结果与一组接受传统脾切除术治疗ITP的历史患者(n = 31)进行比较。脾切除术的反应分为三组:完全缓解、部分缓解和无反应。分组基于血液学数据。
关于手术结果和术后并发症,腹腔镜脾切除术有显著优势。此外,两组的血液学结果在分别经过66个月(开放性脾切除术)和35个月(腹腔镜脾切除术)的中位期后无差异。
腹腔镜脾切除术治疗ITP的短期和长期血液学结果与开放性脾切除术相当。